
Biora Therapeutics Investor Relations Material
Latest events

Q2 2024
Biora Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Biora Therapeutics Inc
Access all reports
Biora Therapeutics Inc. is a biotechnology company focused on developing innovative oral biotherapeutics for the treatment of chronic diseases. The company specializes in creating drug delivery systems that allow for the targeted delivery of therapeutics to the gastrointestinal (GI) tract, aiming to improve treatment outcomes and patient experiences. Biora’s pipeline includes therapies for conditions such as inflammatory bowel disease (IBD) and other GI-related disorders, leveraging its proprietary technology platforms for precision medicine. The company is headquartered in San Diego, California, USA, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
BIOR
Country
🇺🇸 United States